Cardiac PET imaging of ATP binding cassette (ABC) transporters: opportunities and challenges

W Liu, P Mossel, V Schwach, RHJA Slart, G Luurtsema - Pharmaceuticals, 2023 - mdpi.com
Adenosine triphosphate binding cassette (ABC) transporters are a broad family of
membrane protein complexes that use energy to transport molecules across cells and/or …

The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments

C Yu, F Pathan, TC Tan, K Negishi - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Cardio-oncology encompasses the risk stratification, prognostication, identification and
management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular …

Neurotoxic effect of doxorubicin treatment on cardiac sympathetic neurons

N Moro, L Dokshokova, I Perumal Vanaja… - International Journal of …, 2022 - mdpi.com
Doxorubicin (DOXO) remains amongst the most commonly used anti-cancer agents for the
treatment of solid tumors, lymphomas, and leukemias. However, its clinical use is hampered …

Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy

TF de Souza, TQ Silva, L Antunes-Correa, ZD Drobni… - Scientific reports, 2021 - nature.com
There are limited data on the effects of anthracyclines on right ventricular (RV) structure,
function, and tissue characteristics. The goal of this study was to investigate the effects of …

Detection of right ventricular dysfunction by three–dimensional echocardiography and two-dimensional speckle tracking in breast cancer patients receiving …

WS El-Sherbeny, NM Sabry, SB El-Saied, B Elnagar - Cardio-Oncology, 2023 - Springer
Background Despite the cardiotoxic effect of anthracycline on the left ventricle (LV) was
totally identified. The assessment of the anthracycline effect on the right ventricle (RV) by …

The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology

K Keramida, D Farmakis, A Rakisheva… - European Journal of …, 2024 - Wiley Online Library
Cardio-oncology guidelines, position statements and clinical trials have focused on the
cardiotoxic effects of cancer therapies upon the left ventricle. 1, 2 However, cancer …

Modeling Doxorubicin-Induced-Cardiotoxicity Through Breast Cancer Patient Specific iPSC-derived Heart Organoid

J Jang, H Jung, J Jeong, J Jeon, K Lee, HR Jang… - Heliyon, 2024 - cell.com
Heart organoid (HO) technology has successfully overcome the limitations of two-
dimensional (2D) disease modeling and drug testing, thereby emerging as a valuable tool in …

Prevalence of right ventricle strain changes following anthracycline therapy

M Laufer-Perl, M Perelman-Gvili, S Sirota Dorfman… - Life, 2022 - mdpi.com
Background: Anthracycline (ANT) is the most recognized therapy known to cause
cardiotoxicity, mainly left ventricle (LV) dysfunction. Global Longitudinal Strain (GLS) is the …

Cardio-oncology imaging tools at the translational interface

K Yaros, B Eksi, A Chandra, K Agusala… - Journal of Molecular and …, 2022 - Elsevier
Cardiovascular imaging is an evolving component in the care of cancer patients. With
improved survival following prompt cancer treatment, patients are facing increased risks of …

[HTML][HTML] Evaluating right ventricular function to reveal cancer therapy cardiotoxicity

AN Sumin - Russian Open Medical Journal, 2021 - cyberleninka.ru
Advances in cancer treatment resulted in augmented patient survival rate. However,
anticancer therapy often causes heart damage in the form of a progressive systolic heart …